BioLattice Ophthalmics, Inc.

Funding and NIH signals

• SEC Form D raise Raised $575K (Form D filed Mar 30, 2026). SEC Form D 0002125596-26-000001 (Mar 30, 2026)
  Evidence (1 event)

  • Mar 30, 2026 · SEC Form D 0002125596-26-000001
    Name of Issuer: BioLattice Ophthalmics, Inc,; CIK: 2125596; Address: Philadelphia, PA; Submission type: D; Filing date: 2026-03-30; Industry Group: Biotechnology; Date of First Sale: 2026-03-06; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 575000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals